Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BGI Rumored to Stage $400 Million IPO in Late 2014

publication date: Feb 24, 2014
BGI Tech is planning a $400 million IPO in Hong Kong late in 2014. BGI Tech is a division of Shenzhen’s huge genomic sequencing company BGI. The Tech division, which is reponsible for a majority of the parent company's income, provides contract sequencing and bioinformatics services to pharmas, agricultural and environmental companies. The IPO has been rumored since last September. Even though the offering has not yet been officially confirmed, details are starting to emerge. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital